{"pageContent": "Objectives: To evaluate longitudinal changes in urinary function and quality of life, and the oncological outcomes of patients treated with urethra-sparing high-intensity focused ultrasound for localized prostate cancer.", "metaData": {"source": "Which technology to select for primary focal treatment of prostate cancer?-European Section of Urotechnology (ESUT) position statement\nhttps://pubmed.ncbi.nlm.nih.gov/29743538/"}}